All the studies show that mTOR activation occurs in at least 60% of the HPV-caused cancer patients, consistent with the Akt activation data discussed above, suggesting that mTOR activation may play an important role in most of the HPV-induced carcinogenesis. This evidence concerns the gene AKT1 and cancer.